Nautilus Biotechnology Inc (NAUT) - Yalpi foyda koeffitsiyenti

nautilus.bio (NAUT) kompaniyasining rasmiy ramzlari

Nautilus Biotechnology (NAUT) inson xatosini minimallashtiruvchi molekulyar proteom tahlili uchun avtomatlashtirilgan tizimlarni ishlab chiqadi. Bazaviy yalpi foyda operatsion samaradorlik dinamikasini namoyish etadi, bunda -1242.20 belgisi so'nggi ma'lumotlarni aks ettiradi. Yuqori aniqlikdagi protein platformalarining ishlab chiqilishi onkologiyaga qarshi kurashga yordam beradi, farmatsevtika laboratoriyalari uchun IT vositalari bozoriga kengayish esa kompaniyaga uzoq muddatli o'sish potentsialini taqdim etadi.

Yalpi marja: Nautilus Biotechnology Inc (NAUT) 04.07.2022 - 20.11.2026 uchun

Nautilus Biotechnology (NAUT) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
Kompaniyaning asosiy tahlili:NAUT nautilus.bio
Nautilus Biotechnology Inc tomonidan chiqariladigan mahsulotlar

Nautilus Biotechnology (NAUT) proteomika platformasining innovatsion holati barqaror talabni ta'minlaydi, bu esa bevosita xarajatlarni boshqarish samaradorligiga ta'sir qiladi. Yakuniy yalpi foydani tahlil qilish orqali investor tushum ulushidan sotilgan tovarlar tannarxini ayirgan holda ko'ra oladi: ushbu egri chiziqdagi ekstremumlar aktivning haddan tashqari qimmat baholanganligini yoki operatsion xarajatlarning vaqtincha oshishi davrida optimal kirish nuqtasini qidirishni anglatadi.

Asosiy raqobatchilar

Yalpi foyda bo'yicha rentabellik Tempus AI Inc|QGEN (Qiagen NV) - Yalpi marja|Yalpi foyda bo'yicha rentabellik Ionis Pharma (IONS)|Yalpi rentabellik Repligen Corp (RGEN)|RNA - Yalpi foyda marjasi|crisprtx.com - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi WGS|RARE - Yalpi rentabellik|Beam Tx (BEAM) - Yalpi foyda bo'yicha rentabellik|SRPT (Sarepta Therapeutics Inc) - Yalpi foyda bo'yicha rentabellik|TWST: Yalpi foyda koeffitsiyenti|TXG (10xgenomics.com) - Yalpi marja|NTLA (Intellia Therapeutics, Inc.) - Yalpi foyda koeffitsiyenti|Yalpi rentabellik Stoke Corp (STOK)|Yalpi foyda bo'yicha sotuv rentabelligi BioLife|Yalpi marja WVE (Wave Life Sciences Ltd)|MAZE: Sotuvning yalpi rentabelligi|Sionna Therapeutics, Inc. - Yalpi marja|Yalpi foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Yalpi foyda bo'yicha rentabellik|QURE - Yalpi foyda bo'yicha sotuv rentabelligi|MGTX (MeiraGTx Corp) - Yalpi marja|Yalpi foyda marjasi REGENXBIO Inc. RGNX|Yalpi rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Sotuvning yalpi rentabelligi|Yalpi rentabellik Pacific Biosciences PACB|Yalpi foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Yalpi marja|Rocket Pharmaceuticals - Yalpi foyda koeffitsiyenti|Sotuvning yalpi rentabelligi 4D Molecular Therapeutics, Inc.|Yalpi foyda marjasi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Yalpi marja|Yalpi foyda marjasi Editas EDIT|Yalpi marja SLN|ProQR Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja CDXS (Codexis, Inc.)|SGMO: Sotuvning yalpi rentabelligi|MGX: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Precision BioSciences|GBIO (generationbio.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Yalpi marja|Sotuvning yalpi rentabelligi IMNN (Imunon, Inc.)|Yalpi marja PHIO|MBIO - Yalpi foyda marjasi|Yalpi marja RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Yalpi foyda marjasi|Applied DNA - Yalpi marja|Yalpi foyda marjasi Bluebird Bio|ImmunoPrecise (IPA) - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik OMGA (Omega)|Yalpi rentabellik Singular Genomics Systems|Yalpi foyda marjasi regulusrx.com RGLS|Yalpi rentabellik Syros Pharmaceuticals Inc. (SYRS)|Yalpi foyda bo'yicha sotuv rentabelligi Codex DNA|Yalpi rentabellik TRACON TCON|Unity Biotechnology, Inc - Yalpi rentabellik